Cipla Ltd. | CIPLA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 6,188 | 10,039 | 14,012 | 19,285 | 15,646 |
Short-term investment |
| 21,258 | 10,165 | 22,864 | 21,950 | 30,899 |
Accounts receivables |
| 41,507 | 38,913 | 34,457 | 34,244 | 40,570 |
Inventories |
| 39,648 | 43,776 | 46,692 | 53,502 | 51,564 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 15,665 | 14,168 | 14,071 | 18,127 | 29,372 |
Total current assets |
| 124,266 | 117,062 | 132,095 | 147,108 | 168,051 |
Gross property plant... |
| 51,144 | 48,053 | 46,181 | 48,388 | 45,836 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 51,144 | 48,053 | 46,181 | 48,388 | 45,836 |
Work in Progress |
| 3,311 | 4,210 | 5,708 | 3,829 | 6,892 |
Miscellaneous Investment |
| 6,328 | 6,732 | 5,984 | 8,508 | 12,016 |
Deferred income taxes |
| 5,470 | 7,084 | 7,829 | 9,325 | 10,045 |
Intangible assets |
| 19,082 | 19,001 | 18,283 | 17,029 | 15,301 |
Goodwill |
| 28,691 | 29,340 | 30,073 | 31,379 | 29,839 |
Other long-term assets |
| 1,342 | 5,144 | 5,366 | 5,445 | 6,654 |
Total non-current assets |
| 115,367 | 119,564 | 119,424 | 123,903 | 126,582 |
Total assets |
| 239,633 | 236,626 | 251,519 | 271,011 | 294,633 |
Short-term debt |
| 4,862 | 4,472 | 3,347 | 4,079 | 5,204 |
Accounts Payable... |
| 19,480 | 22,818 | 20,668 | 25,081 | 24,571 |
Provisions |
| 7,368 | 9,482 | 10,783 | 12,210 | 12,867 |
Taxes Payable |
| 587 | 93 | 181 | 206 | 166 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 734 | 739 |
Other current liabilities |
| 5,419 | 7,067 | 10,936 | 6,822 | 7,551 |
Total current liabilities |
| 37,715 | 43,931 | 45,916 | 49,132 | 51,097 |
Long-term debt |
| 38,301 | 23,693 | 12,028 | 4,162 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 4,253 | 3,652 | 2,966 | 2,440 | 1,633 |
Provisions |
| 1,214 | 1,333 | 1,162 | 1,002 | 1,022 |
Capital Leases |
| 0 | 0 | 0 | 1,583 | 2,088 |
Other longterm liabilities |
| 4,708 | 3,444 | 3,592 | 1,518 | 1,658 |
Total non-current liabilities |
| 48,476 | 32,121 | 19,748 | 10,705 | 6,401 |
Total liabilities |
| 86,191 | 76,053 | 65,663 | 59,837 | 57,497 |
Share Capital |
| 1,611 | 1,613 | 1,613 | 1,614 | 1,614 |
Share premium |
| 0 | 0 | 0 | 0 | 0 |
Retained earnings |
| 148,511 | 156,018 | 181,652 | 206,803 | 232,464 |
Accumulated other equity |
| 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 3,320 | 2,943 | 2,591 | 2,757 | 3,058 |
Total Equity |
| 153,443 | 160,573 | 185,856 | 211,174 | 237,135 |
Total Liabilities and Equity |
| 239,633 | 236,626 | 251,519 | 271,011 | 294,633 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |